# Thalidomide to Patients With Previously Untreated Multiple Myeloma

> **NCT00218855** · PHASE3 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 363 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** thalidomide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00218855
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2014-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218855, "Thalidomide to Patients With Previously Untreated Multiple Myeloma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00218855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*